113 related articles for article (PubMed ID: 30454700)
1. Role of DDX53 in taxol-resistance of cervix cancer cells in vitro.
Park SY; Kim WJ; Byun JH; Lee JJ; Jeoung D; Park ST; Kim Y
Biochem Biophys Res Commun; 2018 Nov; 506(3):641-647. PubMed ID: 30454700
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
3. DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy.
Kim H; Kim Y; Jeoung D
Mol Cells; 2017 Jan; 40(1):54-65. PubMed ID: 28152297
[TBL] [Abstract][Full Text] [Related]
4. DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2.
Kim Y; Yeon M; Jeoung D
Mol Cells; 2017 May; 40(5):322-330. PubMed ID: 28535666
[TBL] [Abstract][Full Text] [Related]
5. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
6. MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
Zhang W; Zhou J; Zhu X; Yuan H
Gene; 2017 Sep; 627():420-427. PubMed ID: 28669929
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.
Wang Y; Shen F; Zhou J; Fang Y; Qi Y; Chen Y
Drug Dev Res; 2022 Feb; 83(1):142-149. PubMed ID: 34189759
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells.
Lee C
Mol Med Rep; 2015 Jul; 12(1):1485-92. PubMed ID: 25815442
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
Hou Y; Dong Z; Zhong W; Yin L; Li X; Kuerban G; Huang H
Biomed Res Int; 2022; 2022():3032590. PubMed ID: 35141332
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a drug-resistant human cervical cancer cell line and research on its drug-resistance.
Wang H; Zhu Y; Hao C; Fan J; Liu Y; Wang Y
J Cancer Res Ther; 2019; 15(6):1221-1225. PubMed ID: 31898651
[TBL] [Abstract][Full Text] [Related]
12. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
Xia X; Zhou X
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
[TBL] [Abstract][Full Text] [Related]
14. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
Li R; Liu GZ; Luo SY; Chen R; Zhang JX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
[TBL] [Abstract][Full Text] [Related]
15. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
[TBL] [Abstract][Full Text] [Related]
16. Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling.
Peng X; Gong F; Chen Y; Jiang Y; Liu J; Yu M; Zhang S; Wang M; Xiao G; Liao H
Cell Death Dis; 2014 Aug; 5(8):e1367. PubMed ID: 25118927
[TBL] [Abstract][Full Text] [Related]
17. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
18. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
19. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].
Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605
[TBL] [Abstract][Full Text] [Related]
20. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]